Erik Skof (Erik Škof)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Urska Janzic, Andrej Janzic, Abed Agbarya, Urska Bidovec-Stojkovic, Katja Mohorcic, Marina Caks, Peter Korosec, Matija Rijavec, Erik Skof
Prospective Observational Study of COVID-19 Vaccination in Patients with Thoracic Malignancies: Adverse Events, Breakthrough Infections and Survival Outcomes. Biomedicines 12 (3) (2024)
Urska Janzic, Andrej Janzic, Abed Agbarya, Urska Bidovec-Stojkovic, Katja Mohorcic, Marina Caks, Peter Korosec, Matija Rijavec, Erik Skof
Prospective Observational Study of COVID-19 Vaccination in Patients with Thoracic Malignancies: Adverse Events, Breakthrough Infections and Survival Outcomes. Biomedicines 12 (3) (2024)
Simona Miceska, Erik Skof, Gorana Gašljević, Veronika Kloboves Prevodnik
Morphological and Immunocytochemical Characterization of Tumor Spheroids in Ascites from High-Grade Serous Carcinoma. Cells 12 (19) (2023)
Diana Cviič, Kiran Jagarlamudi, Leon Meglič, Erik Skof, Andrej Zore, David Lukanović, Staffan Eriksson, Osredkar J
A Dual Biomarker TK1 Protein and CA125 or HE4-Based Algorithm as a Better Diagnostic Tool than ROMA Index in Early Detection of Ovarian Cancer. Cancers 15 (5) (2023)
Diana Cviič, Kiran Jagarlamudi, Leon Meglič, Erik Skof, Andrej Zore, David Lukanović, Staffan Eriksson, Osredkar J
A Dual Biomarker TK1 Protein and CA125 or HE4-Based Algorithm as a Better Diagnostic Tool than ROMA Index in Early Detection of Ovarian Cancer. Cancers 15 (5) (2023)
Vida Stegel, Ana Blatnik, Erik Skof, Vita Šetrajčič Dragoš, Mateja Krajc, Brigita Gregorič, Petra Škerl, Ksenija Strojnik, Gašper Klančar, Marta Banjac, Janez Žgajnar, Maja Ravnik, Srdjan Novaković
Real-World Data on Detection of Germline and Somatic Pathogenic/Likely Pathogenic Variants in BRCA1/2 and Other Susceptibility Genes in Ovarian Cancer Patients Using Next Generation Sequencing. Cancers 14 (6) (2022)